(IN BRIEF) SCHOTT Pharma has pre-validated its SCHOTT TOPPAC® ISO-standardized polymer cartridge for compatibility with SHL Medical’s Maggie® large-volume autoinjector platform. The collaboration delivers a ready-to-use, de-risked solution for administering highly sensitive biologics in large volumes, supporting self-injection and home-care … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics administration, biosimilars, cell and gene therapy delivery, home care drug delivery, ISO standardized cartridge, large volume drug delivery, Maggie autoinjector, Markus Puusepp, pharmaceutical packaging, polymer cartridge, ready to use packaging, SCHOTT iQ platform, SCHOTT Pharma, SCHOTT Pharma Pre-Validates Polymer Cartridge with SHL Medical’s Maggie Autoinjector Platform, SCHOTT TOPPAC, SCHOTT TOPPAC Polymer Cartridge Achieves Compatibility with SHL Medical Large-Volume Autoinjectors, self injection devices, SHL Medical
(IN BRIEF) SCHOTT Pharma has launched the industry’s first 5.5 ml prefillable staked-needle glass syringe, expanding its syriQ BioPure® platform to support biologic therapies designed for home administration. The syringe integrates seamlessly with Ypsomed’s YpsoMate® 5.5 ml autoinjector and Datwyler’s … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, autoinjector, biologic therapies, biopharmaceuticals, chronic disease treatment, CPHI Frankfurt, Datwyler, drug delivery, glass syringe, Healthcare Innovation, homecare, large-volume injector, medical technology, patient care, pharmaceutical innovation, SCHOTT Pharma, SCHOTT Pharma and Ypsomed drive innovation in large-volume injectable drug delivery with new 5.5 ml syringe, SCHOTT Pharma unveils 5.5 ml BioPure glass syringe to advance home-based biologic treatments, Subcutaneous Injection, syriQ BioPure, tungsten-free syringe, Ulrike Bauer, YpsoMate, Ypsomed
IN BRIEF) SCHOTT Pharma has introduced the SCHOTT TOPPAC® cartridge, the first ready-to-use polymer cartridge to meet ISO dimensions, offering exceptional dimensional precision and broad device compatibility for injection systems such as pens. Made from COC and designed for sensitive … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Andreas Reisse, biologics delivery, COC, CPHI Frankfurt, cross-linked siliconization layer, cyclic olefin copolymer, drug containment solutions, drug stability, glass cartridge portfolio, injection devices, ISO-compliant cartridge, overfill geometry, patient-friendly administration, PDA Universe of Pre-Filled Syringes, pen systems, polymer cartridge, prefillable polymer syringes, ready-to-use cartridge, SCHOTT Pharma, SCHOTT TOPPAC cartridge, St. Gallen manufacturing
(IN BRIEF) SCHOTT Pharma’s Supervisory Board has prolonged CEO Andreas Reisse’s mandate until April 2026, reflecting his pivotal role in driving the company’s emergence as a world-leading manufacturer of pharmaceutical containment and delivery systems. CFO Dr. Almuth Steinkühler will step … Read the full press release
Posted in Business, Financial, Germany, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Almuth Steinkühler, Andreas Reisse, appointment, capital market, CEO extension, CFO Transition, corporate finance, delivery systems, executive leadership, Frankfurt Stock Exchange, Getinge, Hansgrohe, industrial engineering, IPO readiness, ledership, Nilfisk, Peter Goldschmidt, pharmaceutical containment solutions, process digitisation, Reinhard Mayer, SCHOTT Pharma, Supervisory Board, sustainable growth
(IN BRIEF) SCHOTT Pharma has begun construction on a new production facility for ready-to-use (RTU) cartridges at its Lukácsháza site in Hungary. The investment of over 100 million euros will expand the company’s manufacturing capacity to meet increasing demand for … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Hungary, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics, Diabetes, Eva Szabó, expansion, GLP-1 drugs, high-value solutions, hormone therapies, Hungary, insulin, investment, Lukácsháza, manufacturing capacity, Ministry of Foreign Affairs and Trade, Obesity, partnership, pharmaceutical industry, pharmaceutical packaging, ready-to-use cartridges, SCHOTT Pharma, sterile cartridges, sustainability, sustainable development
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?